Abstract
Increasing proportions of elderly patients with hepatocellular carcinoma (HCC) requiring oncological treatment have been noted. We aim to evaluate the impact of elderly age on outcomes of liver resection (LR) for HCC. This retrospective study enrolled 1004 patients with HCC who underwent curative LR in our institution from 2007 to 2017, dividing them into three groups according to age (18–59 years, n = 461; 60–74 years, n = 447; ≥ 75 years, n = 96). Elderly patients were defined as those ≥ 75 years old. Outcomes were then compared among the three groups, with a multivariate competing risk model used to estimate cause-specific subdistribution hazard ratios (SHRs) for HCC- and non-HCC-related deaths. The OS was significantly lower in the elderly than younger patients. However, recurrence-free survival was similar among the three groups. The cumulative incidence of HCC-related death was similar among the three groups; however, the cumulative incidence of non-HCC-related death was significantly higher in the elderly than younger patients. Moreover, the multivariate analysis showed that elderly age was not an independent variable associated with HCC-related death. However, elderly age was an independent variable associated with non-HCC-related death. The 60-year SHR for non-HCC-related death increased with increasing age. The elderly patients had significantly worse OS after LR than the younger patients, possibly due to the cumulative incidence of non-HCC-related death being significantly higher among the elderly than among the younger patients. Elderly patients should be more stringently selected for LR.
Similar content being viewed by others
Data availability
All data are available.
References
Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Kaibori M, Yoshii K, Yokota I et al (2019) Liver cancer study group of Japan. Impact of advanced age on survival in patients undergoing resection of hepatocellular carcinoma: report of a japanese nationwide survey. Ann Surg 269:692–699
European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236 (Electronic address: easloffice@easloffice.eu)
Aldrighetti L, Arru M, Caterini R et al (2003) Impact of advanced age on the outcome of liver resection. World J Surg 27:1149–1154
Cescon M, Grazi GL, Del Gaudio M et al (2003) Outcome of right hepatectomies in patients older than 70 years. Arch Surg 138:547–552
Ezaki T, Yukaya H, Ogawa Y (1987) Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br J Surg 74:471–473
Fortner JG, Lincer RM (1990) Hepatic resection in the elderly. Ann Surg 211:141–145
Lui WY, Chau GY, Wu CW, King KL (1999) Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology 46:640–645
Nagasue N, Chang YC, Takemoto Y et al (1993) Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 113:148–154
Poon RT, Fan ST, Lo CM et al (1999) Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 94:2460–2466
Takenaka K, Shimada M, Higashi H et al (1994) Liver resection for hepatocellular carcinoma in the elderly. Arch Surg 129:846–850
Yamamoto K, Takenaka K, Matsumata T et al (1997) Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 44:514–518
Mizuguchi T, Kawamoto M, Meguro M et al (2015) Impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis. Surg Today 45:259–270
Hung AK, Guy J (2015) Hepatocellular carcinoma in the elderly: meta-analysis and systematic literature review. World J Gastroenterol 21:12197–12210
Zhou Y, Zhang X, Zhang Z et al (2013) Hepatectomy in elderly patients: does age matter? World J Surg 37:2899–2910
Torpy JM, Lynm C, Glass RM (2006) JAMA patient page. Frailty Older Adults JAMA 296:2280
Edge SB, Byrd DR, Compton CC et al (eds) (2010) American joint committee on cancer. American joint committee on cancer staging manual, 7th edn. Springer, New York, p 175
Edmonson H, Steiner P (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503
Everhart JE, Wright EC, Goodman ZD et al (2010) Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51:585–594
Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 018 practice guidance by the American association for the study of liver diseases. Hepatology 68:723–750
European Association for the Study of the Liver, European Organisation For Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
Kokudo N, Hasegawa K, Akahane M, et al (2015) Evidence-based clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res 45(2). https://doi.org/10.1111/hepr.12464
Kudo M, Matsui O, Izumi N et al (2014) Liver cancer study group of Japan. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer 3:458–468
Kudo M, Izumi N, Kokudo N et al (2011) HCC expert panel of Japan society of hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29:339–364
Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474
Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022
Fine JP, Gray RJ (1999) A proportional hazards model for the sub situation of a competing risk. J Am Stat Assoc 94:496–509
Hwang JS, Hu TH, Lee LJ, Wang JD (2017) Estimating lifetime medical costs from censored claims data. Health Econ 26:e332–e344
Muramatsu N, Akiyama H (2011) Japan: super-aging society preparing for the future. Gerontologist 51:425–432
El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264–1273
Cucchetti A, Sposito C, Pinna AD et al (2016) Effect of age on survival in patients undergoing resection of hepatocellular carcinoma. Br J Surg 103:e93–e99
Famularo S, Di Sandro S, Giani A et al (2019) The impact of age and ageing on hepatocarcinoma surgery: short- and long-term outcomes in a multicentre propensity-matched cohort. Liver Int 39:894–904
Xing H, Liang L, Wang H et al (2020) Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma. HPB (Oxford) 22:1314–1323
Acknowledgements
The authors thank Cancer Center, Kaohsiung Chang Gung Memorial Hospital for the provision of HCC registry data. The authors thank Chih-Yun Lin and Nien-Tzu Hsu and the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for statistics work. This study was supported by Grant CMRPG8J1281 from the Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan. No conflict of interests.
Funding
This study was supported by Grant CMRPG8J1281 from the Chang Gung Memorial Hospital-Kaohsiung Medical Center, Taiwan.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [Chih-Chi Wang] and [Yi-Hao Yen]. The first draft of the manuscript was written by [Yueh-Wei Liu] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose for all authors.
Human and animal rights
The Institutional Review Board of Kaohsiung Chang Gung Memorial Hospital approved this study (IRB number: 202000398B0).
Informed consent
The IRB waived the need for informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liu, YW., Yong, CC., Lin, CC. et al. Liver resection in elderly patients with hepatocellular carcinoma: age does matter. Updates Surg 73, 1371–1380 (2021). https://doi.org/10.1007/s13304-021-01021-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-021-01021-7